GHRH (Growth Hormone-Releasing Hormone) vs Pentadeca Arginate (PDA)
Native 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin. versus Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
GHRH (Growth Hormone-Releasing Hormone)
PerformanceNative 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin.
Top benefits
- ✓Pulsatile GH release
- ✓Preserves natural HPA axis
- ✓Reference comparator for analogs
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- ✓Tendon and ligament healing
- ✓Better stability than BPC-157 acetate
- ✓Anti-inflammatory
| Attribute | GHRH (Growth Hormone-Releasing Hormone) | Pentadeca Arginate (PDA) |
|---|---|---|
| Category | Performance | Recovery |
| Type | linear | linear |
| Chain length | 44 aa | 15 aa |
| Formula | C215H358N72O66S | BPC-157 arginate salt |
| Common dose | 1 mcg/kg | 250-500 mcg |
| Frequency | Single bolus IV | 1-2x daily SC |
| Top benefit | Pulsatile GH release | Tendon and ligament healing |
| Top side-effect | Flushing | Injection-site irritation |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.